Search

Your search keyword '"Kari Pulkki"' showing total 218 results

Search Constraints

Start Over You searched for: Author "Kari Pulkki" Remove constraint Author: "Kari Pulkki"
218 results on '"Kari Pulkki"'

Search Results

1. A novel easy-to-use index to predict institutionalization and death in older population – a 10-year population-based follow-up study

2. Predictive value of plasma proenkephalin and neutrophil gelatinase-associated lipocalin in acute kidney injury and mortality in cardiogenic shock

3. A practical laboratory index to predict institutionalization and mortality – an 18-year population-based follow-up study

4. Sleep apnoea is a risk factor for severe COVID-19

5. Novel renal markers for the assessment of renal integrity in patients undergoing knee arthroplasty – a pilot study

6. Hypoalbuminemia is a frequent marker of increased mortality in cardiogenic shock.

7. vWF correlates with visceral and pericardial adipose tissue in patients with a recent stroke of suspected cardiogenic etiology.

8. Acute phase IL-10 plasma concentration associates with the high risk sources of cardiogenic stroke.

9. Glucose Metabolism Effects of Vitamin D in Prediabetes: The VitDmet Randomized Placebo-Controlled Supplementation Study

10. Primary vitamin D target genes allow a categorization of possible benefits of vitamin D₃ supplementation.

11. High pentraxin 3 level predicts septic shock and bacteremia at the onset of febrile neutropenia after intensive chemotherapy of hematologic patients

13. New insights into the genetic etiology of Alzheimer's disease and related dementias

14. A practical laboratory index to predict institutionalization and mortality – an 18-year population-based follow-up study

15. Kinetics of procalcitonin, C-reactive protein and interleukin-6 in cardiogenic shock – Insights from the CardShock study

16. Update on current practice in laboratory medicine in respect of natriuretic peptide testing for heart failure diagnosis and management in Europe. The CARdiac MArker guideline Uptake in Europe (CARMAGUE) study

17. How well do laboratories adhere to recommended guidelines for dyslipidaemia management in Europe? The CArdiac MARker Guideline Uptake in Europe (CAMARGUE) study

18. Tau, S100B and NSE as Blood Biomarkers in Acute Cerebrovascular Events

19. Review of clinical practice guidelines on the use of procalcitonin in infections

20. Serum caspase-cleaved cytokeratin-18 fragment as a prognostic biomarker in hematological patients with febrile neutropenia

21. Febrile neutropenia in patients with acute myeloid leukemia: Outcome in relation to qSOFA score, C-reactive protein, and blood culture findings

22. Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM

23. Angiogenic profile in the Finnish Genetics of Pre-Eclampsia Consortium (FINNPEC) cohort

24. Interleukin-1 receptor antagonist as a biomarker of sepsis in neutropenic haematological patients

25. Fetal Microsatellite in the Heme Oxygenase 1 Promoter Is Associated With Severe and Early-Onset Preeclampsia

26. Opinion: redefining the role of the physician in laboratory medicine in the context of emerging technologies, personalised medicine and patient autonomy (‘4P medicine’)

27. Acute kidney injury in cardiogenic shock: definitions, incidence, haemodynamic alterations, and mortality

28. Soluble Urokinase-type Plasminogen Activator Receptor Predicts All-cause 5-Year Mortality in Ischemic Stroke and TIA

29. Does Rectus Sheath Block Analgesia Alter Levels of the Oxidative Stress Biomarker Glutathione Peroxidase: A Randomised Trial of Patients with Cancer and Benign Disease

30. Genetic architecture of human plasma lipidome and its link to cardiovascular disease

31. MMP-10 and TIMP-1 as indicators of severe sepsis in adult hematological patients with febrile neutropenia

32. Educational Recommendations on Selected Analytical and Clinical Aspects of Natriuretic Peptides with a Focus on Heart Failure: A Report from the IFCC Committee on Clinical Applications of Cardiac Bio-Markers

33. Serum Neurofilament Light Chain Concentration Correlates with Infarct Volume but Not Prognosis in Acute Ischemic Stroke

34. Impact of obesity on angiogenic and inflammatory markers in the Finnish Genetics of Pre-eclampsia Consortium (FINNPEC) cohort

35. Levels of Growth Differentiation Factor 15 and Early Mortality Risk Stratification in Cardiogenic Shock

36. Cardiac troponin and natriuretic peptide analytical interferences from hemolysis and biotin : educational aids from the IFCC Committee on Cardiac Biomarkers (IFCC C-CB)

37. How Well Do Laboratories Adhere to Recommended Clinical Guidelines for the Management of Myocardial Infarction

38. The Cerebrospinal Fluid Distribution of Postoperatively Administred Dexketoprofen and Etoricoxib and Their Effect on Pain and Inflammatory Markers in Patients Undergoing Hip Arthroplasty

39. Plasma level of interleukin-18 and complicated course of febrile neutropenia in hematological patients after intensive chemotherapy

41. Novel renal markers for the assessment of renal integrity in patients undergoing knee arthroplasty – a pilot study

42. Direct Immunoassay for Free Pregnancy-Associated Plasma Protein A (PAPP-A)

43. Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM

44. Novel Biomarker Candidates for Febrile Neutropenia in Hematological Patients Using Nontargeted Metabolomics

45. Plasma Glutathione Peroxidase (GPX1) Levels and Oxidative Stress in Gallstone Patients Operated with Two Different Cholecystectomy Techniques: A Randomized Study with Special Reference to Cancer Patients

47. Camelina Sativa Oil, but not Fatty Fish or Lean Fish, Improves Serum Lipid Profile in Subjects with Impaired Glucose Metabolism-A Randomized Controlled Trial

48. Angiogenic profile and smoking in the Finnish Genetics of Pre-Eclampsia Consortium (FINNPEC) cohort

49. Combined Measurement of Soluble ST2 and Amino-Terminal Pro-B-Type Natriuretic Peptide Provides Early Assessment of Severity in Cardiogenic Shock Complicating Acute Coronary Syndrome

50. Acute kidney injury in cardiogenic shock: definitions, incidence, haemodynamic alterations, and mortality

Catalog

Books, media, physical & digital resources